How do we define efficacy in comparing osteoclast-targeted agents in metastatic breast cancer?

Julie R. Gralow, Allan Lipton, Alison T. Stopeck

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'How do we define efficacy in comparing osteoclast-targeted agents in metastatic breast cancer?'. Together they form a unique fingerprint.